Pharmaceutical compositions comprising a HCV polymerase inhibitor prodrug

Details for Australian Patent Application No. 2010206224 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Chatterji, Ashish; Desai, Dipen; Sandhu, Harpreet K.; Shah, Navnit Hargovindas

Agent Spruson & Ferguson

Pub. Number AU-A-2010206224

PCT Pub. Number WO2010/084041

Priority 61/145,999 21.01.09 US

Filing date 11 January 2010

Wipo publication date 29 July 2010

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

Event Publications

25 August 2011 PCT application entered the National Phase

  PCT publication WO2010/084041 Priority application(s): WO2010/084041

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010206229-Apparatus, method and computer program for obtaining a parameter describing a variation of a signal characteristic of a signal

2010206221-Controlled release pharmaceutical or food formulation and process for its preparation